Please provide your email address to receive an email when new articles are posted on . Patients may now take pregnancy tests outside of a medical setting during and after treatment. If a patient does ...

Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...

Abstract: Computer systems that operate continuously over extended periods of time can be susceptible to a phenomenon known as software aging. This phenomenon can result in the gradual depletion of ...

LawCrossing has introduced a newly updated comprehensive review database focused on BigLaw summer associate programs, providing law students and early-career professionals with a centralized resource ...

(RTTNews) - Organon (OGN) announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for NEXPLANON (etonogestrel implant). NEXPLANON is ...

The transfer portal is just warming ahead of its January 2nd official opening, but it's already busy in the Big Ten. While teams like James Madison and North Texas are suffering wholesale devastation, ...

FME Remote Engines Service is now available on Snowflake Marketplace, allowing secure, scalable data transformations directly inside Snowflake Safe Software, a leading provider of innovative data ...

In an interview with Targeted Oncology, Frederick L. Locke, MD, discussed how the elimination of the REMS program for CAR T-cell therapy came about and what effects he hopes this will have on patient ...

Introduction: Mavacamten is a first-in-class cardiac myosin inhibitor approved by the FDA for the treatment of adults with symptomatic New York Heart Association (NYHA) class II–III obstructive ...

Hannah Cairo shook the math world when she disproved the Mizohata-Takeuchi conjecture, a 40-year-old unsolved math problem, when she was only 17. Well ahead of her peers in math, Cairo applied to ...

Share on Pinterest The FDA recently approved a generic abortion pill that’s considered as safe and effective as mifepristone. Shuran Huang for The Washington Post via Getty Images The approval, ...